Evidence map›Paper›PMID 25762785›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.

Khalid Bin Dhuban, Eva d'Hennezel, Emil Nashi, Amit Bar-Or, Sadiye Rieder, Ethan M Shevach, Satoshi Nagata, Ciriaco A Piccirillo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  9. Article
  10. Article
  11. A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Improving the Efficacy of Regulatory T Cell Therapy.Clinical reviews in allergy & immunology · 2022
    Review
  18. Article
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Khalid Bin DhubanDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec H3G 1A4, Canada; Federation of Clinical Immunology Centre of Excellence, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada;
Eva d'HennezelDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec H3G 1A4, Canada; Federation of Clinical Immunology Centre of Excellence, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada;
Emil NashiDivision of Allergy and Immunology, McGill University Health Centre, Montreal, Quebec H2C 2P2, Canada;
Amit Bar-OrNeuroimmunology Unit, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec H3A 2B4, Canada;
Sadiye RiederLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and.
Ethan M ShevachLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and.
Satoshi NagataCancer Biology Research Center, Sanford Research, Sioux Falls, SD 57104.
Ciriaco A PiccirilloDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec H3G 1A4, Canada; Federation of Clinical Immunology Centre of Excellence, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada; Ciro.piccirillo@mcgill.ca.
McGill University · CAMcGill University Health Centre · CANational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USSanford Research · US

Funding

The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
Studies of Human T Regulatory CellsZIAAI001046 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHEVACH, ETHAN · 2009 to 2025
$10.5M
Canadian Institutes of Health Research MOP67211Canadian Institutes of Health Research MOP84041NIGMS NIH HHS P20 GM103548
6 · The paper itself

Abstract

Two distinct subsets of CD4(+)Foxp3(+) regulatory T (Treg) cells have been described based on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to understand the origin and biological roles of these Treg populations in regulating immune responses have, however, been hindered by the lack of reliable surface markers to distinguish and isolate them for subsequent functional studies. Using a single-cell cloning strategy coupled with microarray analysis of different Treg functional subsets in humans, we identify the mRNA and protein expression of TIGIT and FCRL3 as a novel surface marker combination that distinguishes Helios(+)FOXP3(+) from Helios(-)FOXP3(+) memory cells. Unlike conventional markers that are modulated on conventional T cells upon activation, we show that the TIGIT/FCRL3 combination allows reliable identification of Helios(+) Treg cells even in highly activated conditions in vitro as well as in PBMCs of autoimmune patients. We also demonstrate that the Helios(-)FOXP3(+) Treg subpopulation harbors a larger proportion of nonsuppressive clones compared with the Helios(+)FOXP3(+) cell subset, which is highly enriched for suppressive clones. Moreover, we find that Helios(-) cells are exclusively responsible for the productions of the inflammatory cytokines IFN-γ, IL-2, and IL-17 in FOXP3(+) cells ex vivo, highlighting important functional differences between Helios(+) and Helios(-) Treg cells. Thus, we identify novel surface markers for the consistent identification and isolation of Helios(+) and Helios(-) memory Treg cells in health and disease, and we further reveal functional differences between these two populations. These new markers should facilitate further elucidation of the functional roles of Helios-based Treg heterogeneity.

Indexed as

Immunologic MemoryAutoimmune DiseasesBiomarkersCytokinesFemaleForkhead Transcription FactorsGene Expression ProfilingGene Expression RegulationHumansIkaros Transcription FactorMaleOligonucleotide Array Sequence AnalysisReceptors, ImmunologicT-Lymphocytes, RegulatoryBiomarkersCytokinesFCRL3 protein, humanForkhead Transcription FactorsFOXP3 protein, humanIkaros Transcription FactorIKZF2 protein, humanReceptors, ImmunologicTIGIT protein, human

Identifiers

PMID25762785
PMCPMC4610024
OpenAlexW2147953838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.